CP and myocardial infarction: Pretreatment with CP significantly reduced the infarct size compared with the MI group (Fig. 5b, 29.4 ± 4.0% versus 53.3 ± 3.7%, P = 0.0016, n = 5, one-way ANOVA, Dunnett test).